These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
585 related articles for article (PubMed ID: 23484720)
1. [Changes and clinical significance of CD8(+) T cell subset in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia]. Zhang JY; Xu HZ; Yin DM; Feng XM; Sui XH; Cui B; Ma CY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):203-8. PubMed ID: 23484720 [TBL] [Abstract][Full Text] [Related]
2. [Expressive changes of CD4(+)T cell subset transcription factors in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia and their clinical significances]. Feng XM; Xu HZ; Zhang JY; Yin DM; Liu MM; Sui XH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1038-42. PubMed ID: 25130824 [TBL] [Abstract][Full Text] [Related]
3. Comparison of immunological abnormalities of lymphocytes in bone marrow in myelodysplastic syndrome (MDS) and aplastic anemia (AA). Li X; Xu F; He Q; Wu L; Zhang Z; Chang C Intern Med; 2010; 49(14):1349-55. PubMed ID: 20647647 [TBL] [Abstract][Full Text] [Related]
4. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes]. Wu LY; Li X; Chang CK; Ying SX; Pu Q Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133 [TBL] [Abstract][Full Text] [Related]
5. Comparison of T lymphocyte subsets in aplastic anemia and hypoplastic myelodysplastic syndromes. Zhang HF; Huang ZD; Wu XR; Li Q; Yu ZF Life Sci; 2017 Nov; 189():71-75. PubMed ID: 28935248 [TBL] [Abstract][Full Text] [Related]
6. Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II. Wei J; Zhou XF; Zhao F; Zhou JF; Chen Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):111-6. PubMed ID: 19236759 [TBL] [Abstract][Full Text] [Related]
7. [Changes of HLA-DR15 and immunoglobulin, T lymphocyte subsets in patients with aplastic anemia, myelodysplastic syndrome and their significance]. Cui JX; Pei MF; Zhang GS; Xu M Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):111-5. PubMed ID: 20137129 [TBL] [Abstract][Full Text] [Related]
8. [Analysis of lymphocyte immune abnormality in 52 cases of children idiopathic aplastic anemia]. Chen C; Wei J; Li YF; Huang SL; Fang JP; Zhou DH; Xue HM; Huang K Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1091-5. PubMed ID: 18928602 [TBL] [Abstract][Full Text] [Related]
9. [Analysis of Lymphocyte Subsets in Peripheral Blood of Patients with Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome]. Lv YF; Yan ZY; Chen NY; Wu JH; Liu B; Wang GL; Wang J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1505-1510. PubMed ID: 27784383 [TBL] [Abstract][Full Text] [Related]
10. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome. Zheng Z; Qianqiao Z; Qi H; Feng X; Chunkang C; Xiao L Exp Hematol; 2010 Aug; 38(8):677-84. PubMed ID: 20394797 [TBL] [Abstract][Full Text] [Related]
11. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Maciejewski JP; Hibbs JR; Anderson S; Katevas P; Young NS Exp Hematol; 1994 Oct; 22(11):1102-10. PubMed ID: 7925777 [TBL] [Abstract][Full Text] [Related]
12. Analysis of bone marrow and peripheral blood immunoregulatory lymphocytes in patients with myelodysplastic syndrome. Iwase O; Aizawa S; Kuriyama Y; Yaguchi M; Nakano M; Toyama K Ann Hematol; 1995 Dec; 71(6):293-9. PubMed ID: 8534761 [TBL] [Abstract][Full Text] [Related]
13. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes. Aggarwal N; Swerdlow SH; TenEyck SP; Boyiadzis M; Felgar RE Cytometry B Clin Cytom; 2016 Jul; 90(4):349-57. PubMed ID: 26648320 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the subsets of lymphocytes and their activated status in patients with myelodysplastic syndrome]. Yang J; Wang C; Xie KC; Yan SK; Gao YR; Cai Q; Qin YW; Wan LP; Cai Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):708-13. PubMed ID: 16928305 [TBL] [Abstract][Full Text] [Related]
15. Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry. Huang M; Li J; Zhao G; Sui X; Zhao X; Xu H Int J Lab Hematol; 2010 Jun; 32(3):275-81. PubMed ID: 19968721 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia. Kurotaki H; Tsushima Y; Nagai K; Yagihashi S Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673 [TBL] [Abstract][Full Text] [Related]
17. [Analysis of T cell subsets and CD3zeta chain expression in myelodysplastic syndrome patients]. Xu F; Liu T; Zhu HL; Cui X; Xu CG; Mao YQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):779-82. PubMed ID: 15631660 [TBL] [Abstract][Full Text] [Related]
18. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases. Ghaddar HM; Stass SA; Pierce S; Estey EH Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160 [TBL] [Abstract][Full Text] [Related]
19. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome. PĆ¼lhorn H; Herrmann M; Harms H; Jung A; Baumann I Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734 [TBL] [Abstract][Full Text] [Related]
20. [Expression of G-CSF and GM-CSF receptors on CD34 positive cells in aplastic anemia and myelodysplastic syndrome patients and its significance]. Xu HZ; Li A; Yu Y; Li JF; Liu X; Wang XH; Wang X; Xu GL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1308-11. PubMed ID: 19099633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]